Publications
Published in Top 10% journals in the field
A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022).
Expert Opinion on Therapeutic Patents.
2023,
33(2),
67-87,
ISSN: 1354-3776,
PMID: 36975020,
Pathogenesis of Alzheimer's disease: Involvement of the choroid plexus.
Alzheimer's & Dementia : the Journal of the Alzheimer's Association.
2023,
ISSN: 1552-5260,
PMID: 36825691,
Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance.
Molecular Cancer.
2023,
22(1),
15,
ISSN: 1476-4598,
PMID: 36681803,
Modulating the pharmacokinetic profile of Actinium-225-labeled macropa-derived radioconjugates by dual targeting of PSMA and albumin.
Theranostics.
2022,
12(17),
7203-7215,
ISSN: 1838-7640,
PMID: 36438496,
Characterization of drug effects on cell cultures from phase-contrast microscopy images.
Computers in Biology and Medicine.
2022,
151,
106171,
ISSN: 0010-4825,
PMID: 36306582,
Lupane derivatives containing various aryl substituents in the position 3 have selective cytostatic effect in leukemic cancer cells including resistant phenotypes.
European Journal of Medicinal Chemistry.
2022,
244,
114850,
ISSN: 0223-5234,
PMID: 36283179,
Synthesis of Polycyclic Hetero-Fused 7-Deazapurine Heterocycles and Nucleosides through C-H Dibenzothiophenation and Negishi Coupling.
Journal of the American Chemical Society.
2022,
144(42),
19437-19446,
ISSN: 0002-7863,
PMID: 36245092,